Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)

Shigeo Muro; Hisatoshi Sugiura; Patrick Darken; Paul Dorinsky

doi:10.1186/s12931-021-01803-y

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)

Shigeo Muro, Hisatoshi Sugiura, Patrick Darken, Paul Dorinsky

MED - Medical Sciences

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Abstract

The original version of this article unfortunately contained a mistake [1]. The minor correction of Table 1 was missing. That is, the text ‘FF’ should be ‘GFF’. The correct Table 1 is given in this erratum.

Original language	English
Article number	223
Journal	Respiratory Research
Volume	22
Issue number	1
DOIs	https://doi.org/10.1186/s12931-021-01803-y
Publication status	Published - 2021 Dec

Access to Document

10.1186/s12931-021-01803-y

Fingerprint

Dive into the research topics of 'Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)'. Together they form a unique fingerprint.

Cite this

Muro, S., Sugiura, H., Darken, P., & Dorinsky, P. (2021). Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1). Respiratory Research, 22(1), Article 223. https://doi.org/10.1186/s12931-021-01803-y

Muro, Shigeo ; Sugiura, Hisatoshi ; Darken, Patrick et al. / Corrections to : Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1). In: Respiratory Research. 2021 ; Vol. 22, No. 1.

@article{2fd28b92d7bf4cd08f8bc9817d7983c2,

title = "Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)",

abstract = "The original version of this article unfortunately contained a mistake [1]. The minor correction of Table 1 was missing. That is, the text {\textquoteleft}FF{\textquoteright} should be {\textquoteleft}GFF{\textquoteright}. The correct Table 1 is given in this erratum.",

author = "Shigeo Muro and Hisatoshi Sugiura and Patrick Darken and Paul Dorinsky",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1186/s12931-021-01803-y",

language = "English",

volume = "22",

journal = "Respiratory Research",

issn = "1465-9921",

publisher = "BioMed Central Ltd.",

number = "1",

}

Muro, S, Sugiura, H, Darken, P & Dorinsky, P 2021, 'Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)', Respiratory Research, vol. 22, no. 1, 223. https://doi.org/10.1186/s12931-021-01803-y

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1). / Muro, Shigeo; Sugiura, Hisatoshi; Darken, Patrick et al.
In: Respiratory Research, Vol. 22, No. 1, 223, 12.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrections to

T2 - Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)

AU - Muro, Shigeo

AU - Sugiura, Hisatoshi

AU - Darken, Patrick

AU - Dorinsky, Paul

PY - 2021/12

Y1 - 2021/12

N2 - The original version of this article unfortunately contained a mistake [1]. The minor correction of Table 1 was missing. That is, the text ‘FF’ should be ‘GFF’. The correct Table 1 is given in this erratum.

AB - The original version of this article unfortunately contained a mistake [1]. The minor correction of Table 1 was missing. That is, the text ‘FF’ should be ‘GFF’. The correct Table 1 is given in this erratum.

UR - http://www.scopus.com/inward/record.url?scp=85112833872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112833872&partnerID=8YFLogxK

U2 - 10.1186/s12931-021-01803-y

DO - 10.1186/s12931-021-01803-y

M3 - Comment/debate

C2 - 34372834

AN - SCOPUS:85112833872

SN - 1465-9921

VL - 22

JO - Respiratory Research

JF - Respiratory Research

IS - 1

M1 - 223

ER -

Muro S, Sugiura H, Darken P, Dorinsky P. Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1). Respiratory Research. 2021 Dec;22(1):223. doi: 10.1186/s12931-021-01803-y

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts (Respiratory Research, (2021), 22, 1, (187), 10.1186/s12931-021-01773-1)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this